Long-term outcome of internal sphincter myectomy in patients with internal anal sphincter achalasia

Background  

Internal anal sphincter achalasia (IASA) is a condition with presentation similar to Hirschsprung’s disease (HD), but with the presence of ganglion cells on rectal suction biopsy (RSB). The diagnosis is made on anorectal manometry (ARM) by the absence of the rectosphincteric reflex on rectal balloon inflation. Internal sphincter myectomy (ISM) is the treatment of choice for patients with IASA. Recently, botulinum toxin has been used to treat IASA patients. The purpose of this study was to assess the long-term bowel function in patients with IASA following ISM.